Lymphocyte CD4/CD8 ratio predicts early immune-related toxicity in lung cancer patients treated with immune checkpoint inhibitors: a single-center retrospective study - Poll - MDSpire

Lymphocyte CD4/CD8 ratio predicts early immune-related toxicity in lung cancer patients treated with immune checkpoint inhibitors: a single-center retrospective study

  • By

  • Wenfang Jin

  • Ying Zhao

  • Yanling Lv

  • Yu Yao

  • Xin Su

  • June 8, 2026

  • 0 min

Share

Original Source(s)

Lymphocyte CD4/CD8 ratio predicts early immune-related toxicity in lung cancer patients treated with immune checkpoint inhibitors: a single-center retrospective study

  • by Wenfang Jin, Ying Zhao, Yanling Lv, Yu Yao, Xin Su

  • June 8, 2026

Related Content

Lobectomy versus sublobar resection for stage I non-small cell lung cancer: an umbrella review of evidence quality, overlap, surgical-extent heterogeneity, and survival outcomes

Monomorphic epitheliotropic intestinal T-cell lymphoma presenting as acute small intestinal perforation: a case report and exploratory BCL-2–targeted therapy

Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancer